Intravenous drip. Source: Getty Images Neoadjuvant dd-MVAC improved 5-year overall survival when compared to gemcitabine and cisplatin in a phase 3 trial of patients with MIBC. Dose-dense methotrexate ...
Dose-dense methotrexate plus vinblastine, doxorubicin, and cisplatin improved time to progression. Dose-dense methotrexate plus vinblastine, doxorubicin, and cisplatin (dd-MVAC) can improve outcomes ...
The autophagy–lysosome system is critical for muscle homeostasis and defects in lysosomal function result in a number of inherited muscle diseases, generally referred to as autophagic vacuolar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback